This article examines inflammation's cellular foundations and systemic health impacts, suggesting emerging therapeutic strategies.
Inflammation is a crucial biological process for defending the body and promoting tissue healing. However, when it becomes chronic, it contributes to the development of various contemporary diseases such as diabetes, heart conditions, neurodegenerative disorders, and cancer. This article delves into inflammation's cellular and molecular foundations, emphasizing the involvement of immune cells, cytokines, and critical signaling pathways like NF-κB and JAK-STAT. A range of endogenous and exogenous triggers—from infections and allergens to diet, stress, and environmental pollutants— are examined for their roles in initiating and sustaining inflammation. The systemic health impacts of unresolved inflammation are discussed, with emphasis on metabolic dysfunction, vascular pathology, and neuroimmune dysregulation. The article reviews diagnostic approaches, including biomarkers like CRP and IL-6 and imaging modalities such as PET and MRI. Management strategies encompass pharmacologic agents, lifestyle interventions, and emerging therapies including microbiome-based and personalized approaches. Early detection and integrated therapeutic strategies are critical to mitigating inflammation-related morbidity and advancing precision medicine.
No takes yet. Share an insight, caveat, or question.
Rao et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: